ASH Meeting on Hematologic Malignancies
September 10 - 11, 2021
Hilton Chicago – Chicago, Il and Virtual
Registration for the ASH Meeting on Hematologic Malignancies is now open.
ASH is continually re-assessing the status of our upcoming meetings in light of the COVID-19 pandemic. We encourage you to monitor our various meetings webpages to stay abreast of the latest updates.
The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. The 2021 meeting will be offered in-person and is also available online as a virtual meeting for those unable to participate in person. Participation in the meeting grants participants an opportunity to hear experts present cutting-edge scientific data, provide out-of-the-box treatment approaches, and answer challenging patient care questions during topic-based panel discussions.
The program content is structured with "How I Treat" presentations that showcase speakers’ evidence-based treatment approaches. Learn how new data can be translated into new strategies for diagnosis and treatment, find out what to do in cases where there is no data, and gain knowledge that can help you make an immediate impact on your practice.
Hear exciting updates in each of the core malignancies, including:
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
- Anjali Advani, MD, Cleveland Clinic
- S. Vincent Rajkumar, MD, Mayo Clinic
- Sonali Smith, MD, University of Chicago
Program Planning Committee
- Stephen Ansell, MD, Mayo Clinic
- Partow Kebriaei, MD, MD Anderson Cancer Center
- John Mascarenhas, MD, Mount Sinai Medical School